European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,

United States - English - NLM (National Library of Medicine)

liddell laboratories, inc. - arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), mercuric chloride (unii: 53gh7mzt1r) (mercuric cation - unii:ed30fj8y42), sulfur iodide (unii: l6l8ka2aa0) (sulfur iodide - unii:l6l8ka2aa0), thuja occidentalis leaf (unii: 0t0dqn8786) (thuja occidentalis leaf - unii:0t0dqn8786), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9) - may temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: - minor fever - pain - redness - swelling -weakness - lack of energy** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. may temporarily relieve the ill effects -  not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: - minor fever - pain - redness - swelling -weakness - lack of energy** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

liddell laboratories, inc. - arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), mercuric chloride (unii: 53gh7mzt1r) (mercuric cation - unii:ed30fj8y42), sulfur iodide (unii: l6l8ka2aa0) (sulfur iodide - unii:l6l8ka2aa0), thuja occidentalis leaf (unii: 0t0dqn8786) (thuja occidentalis leaf - unii:0t0dqn8786), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9) - may temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: • minor fever • pain • redness • weakness • lack of energy • swelling** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: • minor fever • pain • redness • weakness • lack of energy • swelling** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

liddell laboratories, inc. - arnica montana whole (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), hypericum perforatum whole (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb), rhododendron tomentosum leafy twig (unii: 877l01iz0p) (ledum palustre twig - unii:877l01iz0p), measles virus (unii: ht3r7c012q) (measles virus - unii:ht3r7c012q), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), sulfur iodide (unii: l6l8ka2aa0) (sul - may temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: • minor fever • pain • redness • weakness • lack of energy • swelling** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve the ill effects - not the therapeutic effects - of oral or injected vaccines. children and adults may expect temporary relief from symptoms such as: • minor fever • pain • redness • weakness • lack of energy • swelling** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus b; hepatitis b vaccines; pertactin; pertussis toxoid (pt); poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated; tetanus toxoid - powder and suspension for suspension for injection - filamentous haemagglutinin (fha) 25 mcg/dose; diphtheria toxoid nlt 30 iu/dose; tetanus toxoid nlt 40 iu/dose; hepatitis b vaccines 10 mcg/dose; poliovirus type 1 inactivated 40 du/dose; poliovirus type 2 inactivated 8 du/dose; poliovirus type 3 inactivated 32 du/dose; haemophilus b 10 mcg/dose; pertactin 8 mcg/dose; pertussis toxoid (pt) 25 mcg/dose - bacterial and viral vaccines, combined - infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and disease caused by haemophilus influenza type b for infants between 6 weeks and 36 months of age.

Ireland - English - HPRA (Health Products Regulatory Authority)

gsk vaccines s.r.l. - meningococcal group c oligosaccharide; corynebacterium diphtheriae crm197 protein - suspension for injection in pre-filled syringe - 10 - meningococcal vaccines; other meningococcal polyvalent purified polysaccharides antigen - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

United Kingdom - English - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

United Kingdom - English - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

European Union - English - EMA (European Medicines Agency)

gsk vaccines s.r.l. - outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant neisseria meningitidis group b fhbp fusion protein, recombinant neisseria meningitidis group b nada protein, recombinant neisseria meningitidis group b nhba fusion protein - meningitis, meningococcal - meningococcal vaccines - active immunisation against invasive disease caused by neisseria meningitidis serogroup-b strains.,